HCV isolation in hemodialysis units

HCV isolation in hemodialysis units refers to placing HCV-positive patients in separate wards or assigning them separate dialysis monitors, usually as a strategy to prevent bloodborne transmission within the unit. Its emergence reflects the transformation of hepatitis C from a largely transfusion-associated threat into a recognized healthcare-associated risk: as blood screening improved and transfusion-related transmission declined, attention increasingly turned to transmission occurring during hemodialysis care.

Origins and Rationale

In the early 1990s, hemodialysis patients were recognized as a high-risk population for HCV infection. Prevalence was associated with time on dialysis, was higher among hemodialysis patients than among those receiving peritoneal dialysis or home hemodialysis, and remained substantial even among patients who had never received transfusions. The older transfusion risk had nevertheless fallen dramatically, from about 0.5% per blood unit in the 1980s to approximately 0.0001%, or one case per million blood units, in the United States. This change shifted concern toward nosocomial transmission inside dialysis units.

The isolation policy was therefore a precautionary response to a plausible and sometimes intense risk. Spain, where HCV prevalence had initially exceeded 30%, adopted separation of HCV-positive patients by ward or monitor while reinforcing hygienic precautions. Other settings, including most Belgian units, concentrated on hygiene without routine isolation. Supporters of isolation argued that every available measure should be used, particularly in units with high recent seroconversion rates. Opponents emphasized the long interval between infection and seroconversion, HCV's lower infectivity than hepatitis B virus, the logistical burden of maintaining multiple wards for patients with different infection statuses, and the possibility that isolation could expose patients to multiple HCV genotypes.

Evidence from Transmission Investigations

The epidemiology of the period established that transmission was occurring in hemodialysis environments, but it did not establish that patient isolation was the mechanism capable of stopping it. From the mid-1990s onward, molecular virology studies used sequence variation in HCV isolates to identify clusters of closely related viruses among patients treated in the same unit. These phylogenetic findings unequivocally demonstrated nosocomial transmission, although the precise route could rarely be reconstructed after the event.

A KDIGO workgroup reviewed 20 such studies, each involving newly diagnosed HCV-positive hemodialysis patients and epidemiologic information about possible source patients. None conclusively established a specific transmission route. All, however, pointed to failures in infection-control procedures as the probable cause. In 18 of the 20 studies, some or all newly infected patients had not shared a dialysis machine with the presumed source patient; they had either been treated at the same time or had been assigned machines different from those used by HCV-positive patients. The internal fluid pathway of the dialysis machine was considered a possible route in only one study, indicating that the machine circuit played, at most, a small role in transmission.

The same evidence also weakened the case for dedicated machines. Because new infections commonly occurred without shared machines, the KDIGO workgroup concluded that dedicated dialysis machines for HCV-infected patients were not recommended. The finding redirected responsibility toward the practices surrounding the machine: hand hygiene, glove use, handling of equipment, and prevention of contamination at the dialysis station.

Policy Assessment and Recommended Practice

Although HCV incidence and prevalence subsequently declined in many countries, the available before-and-after and A-B studies could not prove that isolation caused the improvement because they lacked randomized controls or, in many cases, a genuine comparison group. The decline was compatible with several simultaneous changes, including safer blood supplies and improved infection-control practice.

The strongest comparative evidence came from two large prospective observational studies, the Dialysis Outcomes and Practice Patterns Study and an Italian study. After multivariable adjustment for potential confounders, including the prevalence of HCV infection within each hemodialysis unit, neither study found that isolation protected patients from HCV transmission. On this basis, the KDIGO workgroup did not recommend isolating HCV-positive patients as an alternative to strict infection-control procedures for preventing bloodborne pathogens. The recommendation was weak, reflecting the absence of randomized trials, but its practical direction was clear: separation could not substitute for reliable precautions.

The recommended approach placed routine hygiene at the center of prevention. Staff were expected to wash their hands with soap or antiseptic handwash and water before and after contact with a patient or with equipment at the dialysis station. Alcohol-based hand rub was acceptable when hands were not visibly contaminated. Disposable gloves were required when caring for a patient or touching potentially contaminated surfaces, and gloves were to be removed when leaving the station. These measures addressed the likely pathway identified by the molecular studies more directly than the physical separation of patients.

Significance for Hemodialysis Practice

The history of HCV isolation in hemodialysis units illustrates the difference between recognizing a real hazard and identifying an effective intervention. HCV infection is a systemic disease capable of affecting the liver, kidneys, and other organs, and patients with chronic kidney disease may face severe consequences from infection. Yet the existence of a serious infection did not make every visible barrier equally useful. Isolation made risk legible and may have heightened staff awareness in some settings, but the evidence did not demonstrate an independent protective effect.

The resulting policy favored a less dramatic but more demanding form of prevention. Rather than treating HCV-positive patients as the sole location of danger, it treated transmission as a failure of procedures that could occur across ordinary clinical contact. Strict infection control therefore became the essential safeguard, while routine isolation and dedicated machines lost their status as necessary measures. The central lesson was not that transmission was unimportant, but that preventing it depended on disciplined practice throughout the dialysis unit.